Literature DB >> 22673726

Use of fractional dose-volume histograms to model risk of acute rectal toxicity among patients treated on RTOG 94-06.

Susan L Tucker1, Jeff M Michalski, Walter R Bosch, Radhe Mohan, Lei Dong, Kathryn Winter, James A Purdy, James D Cox.   

Abstract

BACKGROUND AND
PURPOSE: For toxicities occurring during the course of radiotherapy, it is conceptually inaccurate to perform normal-tissue complication probability analyses using the complete dose-volume histogram. The goal of this study was to analyze acute rectal toxicity using a novel approach in which the fit of the Lyman-Kutcher-Burman (LKB) model is based on the fractional rectal dose-volume histogram (DVH).
MATERIALS AND METHODS: Grade ≥2 acute rectal toxicity was analyzed in 509 patients treated on Radiation Therapy Oncology Group (RTOG) protocol 94-06. These patients had no field reductions or treatment-plan revisions during therapy, allowing the fractional rectal DVH to be estimated from the complete rectal DVH based on the total number of dose fractions delivered.
RESULTS: The majority of patients experiencing Grade ≥2 acute rectal toxicity did so before completion of radiotherapy (70/80=88%). Acute rectal toxicity depends on fractional mean rectal dose, with no significant improvement in the LKB model fit when the volume parameter differs from n=1. The incidence of toxicity was significantly lower for patients who received hormone therapy (P=0.024).
CONCLUSIONS: Variations in fractional mean dose explain the differences in incidence of acute rectal toxicity, with no detectable effect seen here for differences in numbers of dose fractions delivered.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22673726      PMCID: PMC3413409          DOI: 10.1016/j.radonc.2012.04.023

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  19 in total

1.  Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.

Authors:  Stephanie T H Peeters; Mischa S Hoogeman; Wilma D Heemsbergen; Augustinus A M Hart; Peter C M Koper; Joos V Lebesque
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-06-06       Impact factor: 7.038

2.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

3.  Predictors for rectal and intestinal acute toxicities during prostate cancer high-dose 3D-CRT: results of a prospective multicenter study.

Authors:  Vittorio Vavassori; Claudio Fiorino; Tiziana Rancati; Alessandro Magli; Gianni Fellin; Michela Baccolini; Carla Bianchi; Emanuela Cagna; Flora A Mauro; Angelo F Monti; Fernando Munoz; Michele Stasi; Paola Franzone; Riccardo Valdagni
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-01-22       Impact factor: 7.038

Review 4.  Radiation dose-volume effects in radiation-induced rectal injury.

Authors:  Jeff M Michalski; Hiram Gay; Andrew Jackson; Susan L Tucker; Joseph O Deasy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

5.  Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy.

Authors:  Barbara A Jereczek-Fossa; Dario Zerini; Cristiana Fodor; Luigi Santoro; Flavia Serafini; Raffaella Cambria; Andrea Vavassori; Federica Cattani; Cristina Garibaldi; Federica Gherardi; Annamaria Ferrari; Bernardo Rocco; Epifanio Scardino; Ottavio de Cobelli; Roberto Orecchia
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-02-03       Impact factor: 7.038

6.  Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Authors:  Stephanie T H Peeters; Wilma D Heemsbergen; Wim L J van Putten; Annerie Slot; Hans Tabak; Jan Willem Mens; Joos V Lebesque; Peter C M Koper
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-03-15       Impact factor: 7.038

7.  Mathematical model for evaluating incidence of acute rectal toxicity during conventional or hypofractionated radiotherapy courses for prostate cancer.

Authors:  Lidia Strigari; Giorgio Arcangeli; Stefano Arcangeli; Marcello Benassi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-11-05       Impact factor: 7.038

8.  Acute toxicity in definitive versus postprostatectomy image-guided radiotherapy for prostate cancer.

Authors:  Jonathan C Cheng; Timothy E Schultheiss; Khanh H Nguyen; Jeffrey Y C Wong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-12-31       Impact factor: 7.038

9.  Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.

Authors:  Jeff M Michalski; Kyounghwa Bae; Mack Roach; Arnold M Markoe; Howard M Sandler; Janice Ryu; Matthew B Parliament; William Straube; Richard K Valicenti; James D Cox
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

10.  Acute toxicity after hypofractionated conformal radiotherapy for localized prostate cancer: nonrandomized contemporary comparison with standard fractionation.

Authors:  Felix Leborgne; Jack Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-28       Impact factor: 7.038

View more
  6 in total

1.  Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.

Authors:  J A Dean; L C Welsh; K H Wong; A Aleksic; E Dunne; M R Islam; A Patel; P Patel; I Petkar; I Phillips; J Sham; U Schick; K L Newbold; S A Bhide; K J Harrington; C M Nutting; S L Gulliford
Journal:  Clin Oncol (R Coll Radiol)       Date:  2017-01-03       Impact factor: 4.126

2.  Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers.

Authors:  Xiaonan Liu; Jing Li; Teresa Wu; Steven E Schild; Michael H Schild; William Wong; Sujay Vora; Mirek Fatyga
Journal:  OMICS J Radiol       Date:  2016-06-13

3.  Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy.

Authors:  Jamie A Dean; Kee H Wong; Hiram Gay; Liam C Welsh; Ann-Britt Jones; Ulrike Schick; Jung Hun Oh; Aditya Apte; Kate L Newbold; Shreerang A Bhide; Kevin J Harrington; Joseph O Deasy; Christopher M Nutting; Sarah L Gulliford
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-08-22       Impact factor: 7.038

4.  Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?

Authors:  X Liu; J Li; S E Schild; M H Schild; W Wong; S Vora; M G Herman; M Fatyga
Journal:  OMICS J Radiol       Date:  2018-12-03

5.  Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.

Authors:  Jamie A Dean; Kee H Wong; Liam C Welsh; Ann-Britt Jones; Ulrike Schick; Kate L Newbold; Shreerang A Bhide; Kevin J Harrington; Christopher M Nutting; Sarah L Gulliford
Journal:  Radiother Oncol       Date:  2016-05-27       Impact factor: 6.280

6.  Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy.

Authors:  Jamie Dean; Kee Wong; Hiram Gay; Liam Welsh; Ann-Britt Jones; Ulricke Schick; Jung Hun Oh; Aditya Apte; Kate Newbold; Shreerang Bhide; Kevin Harrington; Joseph Deasy; Christopher Nutting; Sarah Gulliford
Journal:  Clin Transl Radiat Oncol       Date:  2017-11-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.